Genotype Stratified Treatment With Anticholinergic vs. [versus] Beta-Agonist (Long Acting) and Exacerbations (GABLE)

Trial Profile

Genotype Stratified Treatment With Anticholinergic vs. [versus] Beta-Agonist (Long Acting) and Exacerbations (GABLE)

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 05 May 2017

At a glance

  • Drugs Tiotropium bromide (Primary) ; Corticosteroids; Formoterol; Salmeterol
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms GABLE
  • Most Recent Events

    • 21 Mar 2012 Actual patient number is 355 according to ClinicalTrials.gov.
    • 21 Mar 2012 Planned end date changed from 1 Aug 2011 to 1 Sep 2011 as reported by ClinicalTrials.gov.
    • 21 Mar 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top